Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Blume-Jensen Peter
President and CEO at Acrivon Therapeutics. Filing since 14 Jan 2026.
CIK 0001950499
Company
Date
Role
Action
Shares
Amount
Of holding
ACRV
Acrivon Therapeutics, Inc.
25 Aug 2026
President and CEO
Sold at will
14,036
$30.97K
0.6%
ACRV
Acrivon Therapeutics, Inc.
18 Aug 2026
President and CEO
Sold at will
1,229
$2.47K
0.1%
ACRV
Acrivon Therapeutics, Inc.
18 Aug 2026
President and CEO
Sold at will
484
$972.84
0.1%
ACRV
Acrivon Therapeutics, Inc.
14 Jan 2026
President and CEO
Bought
49,000
$82.12K
2.4%
4 decisions on file.
